Index waiver program, 19 24
medical diagnosis, vs. nutrition diagnosis, 53 medical home, 26
medical nutrition therapy (MNT), 50, 108, 167, 348
liver disease, 178–179, 180–181 oral health and, 137 renal disease, 169
Medicare, 9, 19, 21, 23, 24, 79, 108, 125, 135, 263, 285, 301, 302, 303, 309, 310, 314, 317, 326, 329. See also Centers for Medicare & Medicaid Services (CMS) Medicare Payment Advisory Commission (MedPAC), 286 medications, 74, 77, 110, 237 administration, 258 anorexia, 110 appetite and, 6, 113, 120–121 esophageal injury and, 148 folate antagonists, 163
gastrointestinal symptoms and, 8–9, 196–197, 238
glucose-lowering, 177, 180–181, 184–185 hydration and, 75, 124, 125 involuntary weight loss and, 7 iron loss, 161
nutrient requirements and, 6, 11–12 parenteral feedings, 261–262 polypharmacy pattern, 109 side effects, 234–273 swallowing and, 83–84, 148 taste loss, 7–8, 183 xerostomia and, 135, 148
Megace. See megastrol acetate
megaloblastic anemia, 83, 161, 163, 164, 220, 222, 223, 228
megastrol acetate, 120 meglitinides, 184
menu development, 25, 34, 275
metabolism, 171, 199, 235, 236, 219, 220, 237, 247
methotrexate, 166–167, 216, 219, 220, 237, 247 micronutrients, 12, 178, 179–180 parenteral feeding, 261, 263 pressure ulcers and, 202
Mifflin-St Jeor equation, 82, 87, 106, 254 mild cognitive impairment, 9. See also cognitive impairment
minerals, 83, 255
drug interactions, 235, 249 pressure ulcers and, 202, 208–210 supplements, 192
Minimum Data Set (MDS), 75, 82, 131, 301, 303, 304, 305, 306, 307, 311, 315, 320–321 Mini Nutritional Assessment (MNA), 74, 108, 116, 136, 151, 178, 251 mirtazapine, 62, 64, 121 MNT. See medical nutrition therapy (MNT) Modified Diet in Renal Disease (MDRD), 169, 172
molybdenum, 12
monitoring, 55–56, 57, 113–114, 123, 127, 203, 259, 262, 263, 317, 323, 334
monoamine oxidase inhibitors (MAOI), 222, 237–238, 247, 249, 250 monoamines. See pressor amines mortality, 79–80, 125, 171, 178 weight loss and, 10 motor control, 41, 44, 86 mouth, 83, 98, 140, 143, 283 sore, 190, 194, 196
multiple sclerosis, 41, 85, 137, 155 muscle wasting, 107, 127 musculoskeletal system, 8 myelosuppression, 187, 190
nails, 99, 161 naproxen, 247
narcotic analgesic, 7, 249 nasogastric/enteric tube feeding. See feeding tubes National Cancer Institute, 190 National Center for Complementary and Alternative Medicine, 190, 195 National Center for Health Statistics, 3, 17. See also National Health and Nutrition Examination Survey (NHANES)
National Comprehensive Cancer Network (NCCN), 191
NCCN Guidelines: Older Adult Oncology, 191
National Dysphagia Diet (NDD), 152 National Health and Nutrition Examination Survey (NHANES), 3, 17 National Hospital Discharge Survey, 122 National Incident Management System, 360 National Institute of Food and Agriculture (NIFA), 22
National Kidney Foundation Kidney Disease
393
Previous Page